Axceler8 Solutions: Built for Speed. Designed for Impact.
Accelerating innovation through intelligent digital solutions.
Axceler8 Solutions designs, develops, and operates digital platforms that transform how organizations work. We build scalable solutions that automate complexity, enhance decision-making, and accelerate measurable outcomes across industries.
Our mission: to help businesses move from vision to impact—faster.
Axceler8 Rx: Clinical Trial Acceleration, Powered by Arthur D. Little and Vega IT
Axceler8 Rx is a proven, AI-driven platform for accelerating clinical trials — already deployed in global studies across therapy areas (e.g., oncology, neurology, immunology, cardiovascular, rare diseases, etc.).
Built by Arthur D. Little’s clinical-trial acceleration experts in cooperation with Vega IT as their tech partner, and based on experience supporting over 100 trials across several of the top ten major pharma companies, Axceler8 Rx helps sponsors identify the right countries and sites, predict enrollment outcomes with precision, and accelerate activation and performance. Axceler8 Rx platform modules are currently being used in over 30 global trials across multiple therapeutic areas.
Our founders
Axceler8 Solutions was born from the partnership between Arthur D. Little (ADL) and Vega IT—two organizations driven by a shared ambition to accelerate digital transformation at scale. Blending ADL’s 135-year legacy of strategic insight with Vega IT’s engineering excellence, Axceler8 Solutions brings together the best of both worlds: deep industry knowledge and cutting-edge technology execution.
This unique combination enables us to transform complexity into clarity, delivering intelligent, high-performance digital platforms that help clients achieve speed, precision, and measurable impact.
Ready to compress
time and unlock value?
Let’s build smarter systems that do more, faster — so you can focus on what matters most.
